|
The American Stock Exchange (Amex) has a long history in the U.S. equity market and today is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRSSM. The Amex’s status as a national exchange affords Amex-listed companies Blue Sky exemption from state securities laws in all 50 states. In addition to its role as a national equities market with approximately 600 listed companies, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993 and launching a whole new investment category that has grown to more than $300 billion in assets. The Amex remains the center of ETF development and the global ETF market leader, with more than 180 listed ETFs. The Amex is also one of the largest options exchanges in the U.S., trading options in nearly 2000 domestic and foreign equities and ETFs as well as broad-based and sector indexes. The Auction and Electronic Market Integration (AEMISM) platform is Amex's new, state-of-the-art trading platform whose launch will coincide with the implementation of the Order Protection Rule as part of Regulation NMS. AEMI will support Amex's hybrid market structure, which offers market participants automated execution combined with an auction market. The auction market provides dedicated liquidity in times of order imbalances, complex trades, or when natural liquidity cannot be found. The fusion of automated execution and the auction market will meet the future needs of Amex customers — the investing public, institutional traders, liquidity providers and listed companies — and will ensure that Amex will be competitive in the post-Regulation NMS environment. The Amex is the only exchange to offer a suite of visibility-enhancing programs and investor relations (IR) services to listed companies. The Amex IR AllianceSM (AIRA) provides a full communications audit, IR hotline, seminars and Amex Online, an advanced targeting tool for finding new institutional shareholders and conducting in-depth market and peer analysis. Each listed company is also assigned an issuer services director who works closely with Amex management to maximize the full value of AIRA services. Together, these tools can help to enhance demand for a company’s stock among both retail and institutional investors. While its market structure and customized services benefit companies of every size and stage of development, the Amex specializes in providing an efficient market for small and mid-sized companies striving for enhanced visibility and institutional ownership. Companies select their own specialist, who has an obligation to make a fair and orderly market in their stock. Amex specialists and traders form one of the largest pools of capital available for customer execution in the world. While Amex stocks are predominantly small-cap or middle market, its listed companies represent many diverse industries, including banks and financial services, healthcare products and services, wholesale and retail trade, real estate and REITs, technology, communications, natural resources and industrial and consumer manufacturing, and countries around the world, including Canada, China, Israel, Italy, New Zealand, Taiwan and the United Kingdom. American Stock Exchange, 86 Trinity Place, New York, NY 1006 |
 |
|
Cornell Capital Partners provides innovative financing solutions to growing companies in the small and mid-cap sectors worldwide. We work closely with management to design custom-tailored, alternative financing structures that meet the companies’ capital needs and corporate goals. Launched in 2001 and the pioneer of the Standby Equity Distribution AgreementSM (“SEDA”), an innovative capital funding mechanism, Cornell Capital has committed during the previous 12 months over $875M in capital to over 100 companies listed in the US, UK, Australia, Brazil, Singapore, Malaysia, Italy and Hong Kong. For the last two years, Cornell Capital has remained #1 on Knobias league tables for US transactions in terms of number of transactions completed and transactional value (Knobias Pipe-Trac 2004-2005). Our team provides unique solutions to unique problems. We assist emerging companies, public or private, with a range of financing options such as straight equity purchases, structured equity financing, convertibles, equity-linked notes, and asset-backed loans. |
 |
|
Edwards Angell Palmer & Dodge LLP has been at the forefront of life sciences for more than 20 years representing 150 public and private life sciences companies and some of the premier venture capital and investment banking firms that invest in that industry. Large pharmaceutical companies and emerging biotech companies turn to us on a variety of issues, including intellectual property, licensing and collaboration, mergers and acquisitions, capital raising, FDA counseling and international partnering. Our more than 100 lawyers, many of whom have advanced degrees, represent companies in all stages of development from true start-ups, to VC finance development stage companies, to publicly traded industry leaders. |
 |
| Katan
Associates
Your Global Capitalization
Partner Based in the world’s leading centers for biotechnology and biomedicare, Katan Associates brings together specialists from a diverse range of corporate and commercial backgrounds to advise firms on long term growth and capitalization solutions. Katan Associates focuses on five core areas of specialization in helping firms achieve their business growth.
Katan provides businesses and management teams with the tools and the infrastructure to grow and expand their business. To find out more, please visit our website at www.katanassociates.com Or contact Seth Yakatan, Partner, at 323.356.6321 or seth@katanassociates.com |
|
